Clinical Trials Browser

Breast Neoplasms

NCT05376878 2026-02-23

An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis

Phase 4 Recruiting

10 enrolled

BreastCNS

Brain Neoplasms, Breast Neoplasms

NCT02810873 2025-05-04

Positron Emission Tomography Imaging Using Copper Cu 64 TP3805 in Patients With Breast Cancer

Phase NA Terminated

19 enrolled 7 charts

Breast

Breast Neoplasms

NCT05632601 2024-11-04

HER-CROWN

Phase NA Recruiting

210 enrolled

BreastGynecologic

Breast Neoplasms, Cardiovascular Diseases, Polycystic Ovary Syndrome, Toxemia, Diabetes, Gestational, Primary Ovarian Insufficiency

NCT06586047 2024-09-19

Breast Cancer PSMA PET

Phase NA Recruiting

30 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT03057743 2021-11-18

Imaging of in Vivo Sigma-2 Receptor Expression With 18F-ISO-1 Positron Emission Tomography in Metastatic Breast Cancer

Terminated

4 enrolled

Breast

Breast Neoplasms

NCT01479348 2020-06-02

Imaging Study for FdCyd and THU Cancer Treatment

Phase EARLY_PHASE1 Terminated

5 enrolled 12 charts

BreastGenitourinaryHead & NeckThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Neoplasms

NCT02437539 2015-08-24

uPAR-PET

Phase 1 Completed

10 enrolled

BreastGenitourinary

Urinary Bladder Neoplasms, Breast Neoplasms, Prostatic Neoplasms

Clinical Trials

Using Diagnostic Tools to Stage Breast Cancer

An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis

Positron Emission Tomography Imaging Using Copper Cu 64 TP3805 in Patients With Breast Cancer

HER-CROWN

Breast Cancer PSMA PET

Imaging of in Vivo Sigma-2 Receptor Expression With 18F-ISO-1 Positron Emission Tomography in Metastatic Breast Cancer

Imaging Study for FdCyd and THU Cancer Treatment

uPAR-PET